[WSJ] Paying for the Thousand-Dollar Pill

In The Wall Street Journal, AHIP President and CEO Karen Ignagni writes that specialty drugs account for 25% of U.S. drug costs. Health plans need to know more about them.


Read More

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.